Supplementary Figure S5 from Safety and Efficacy of Axicabtagene Ciloleucel Versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma
crossref(2023)
Key words
CAR T Cells
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined